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Purpose: To identify the disease-causing gene in a four-generation Chinese family affected with autosomal dominant
aniridia and cataract.
Methods: All patients underwent full ophthalmic examination. For mutation analysis, a partial coding region (exons 5–
14) of paired box gene 6 (PAX6) was sequenced with DNA from the proband. Single-strand conformation polymorphism
analysis for exon 5 of PAX6 was performed to demonstrate co-segregation of the PAX6 mutation with aniridia in all family
members and the absence of the mutation in the normal controls.
Results: The proband and other patients in the family were affected with aniridia accompanied with congenital cataract.
A novel heterozygous PAX6 mutation in exon 5 (c.475_491del17, p.Arg38ProfsX12) was identified, which was predicted
to generate a frameshift and create a premature termination codon. This mutation co-segregated with the affected
individuals in the family and did not exist in unaffected family members and 100 unrelated normal controls.
Conclusions: A novel deletion mutation in the PAX6 gene was identified in a Chinese family with aniridia and congenital
cataract. Our study expands the mutation spectrum of PAX6.
Barratta  [1]  first  described  aniridia  in  1818  (OMIM
106210). Although called aniridia (Greek for absence of the
iris),  this  disorder  is  not  just  an  isolated  defect  in  iris
development but is a panocular disorder that involves the lens,
optic nerve, cornea, anterior chamber, and retina [2]. Aniridia
occurs  in  the  general  population  at  a  frequency  of
approximately 1 in 64,000–96,000, and two-thirds of cases are
familial with autosomal dominant inheritance with complete
penetrance but variable expressivity [3].
Paired box gene 6 (PAX6), a member of the paired box
gene  family,  is  located  on  chromosome  11p13.  PAX6  is
divided into 14 exons that span over 22 kb in length [4]. The
polypeptide product possesses several functional domains: a
paired  domain  and  a  homeodomain  separated  by  a  linker
segment and followed by a COOH-terminal region rich in
proline, serine, and threonine [5]. The paired domain, which
is encoded by exons 5–7 of PAX6, comprises two structurally
distinct subdomains, the relatively conserved NH2 terminal
(NTS) and the variable COOH terminal [6,7]. PAX6 plays a
major role in the organization of the developing eye [3], and
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various heterozygous mutations in PAX6 have been identified
in patients with aniridia. To date over 20 different PAX6
mutations, which have been reported in the Human PAX6
Allelic Variant Database [8], are associated with aniridia and
congenital cataract.
In this study, we analyzed the coding sequences of PAX6
in a large Chinese family and identified a novel frameshift
mutation that causes aniridia and cataract.
METHODS
Patients: We investigated a large family that originated from
the central region of China. Seven living patients with aniridia
and congenital cataract were identified. Informed consent was
obtained from the participants in accordance with the study
protocols approved by the ethics committee of Union Hospital
of Huazhong University of Science and Technology, Wuhan,
China.  The  proband  in  this  family  received  a  complete
ophthalmic evaluation, and the other five subjects (ocular data
of II-11 could not be obtained) underwent ocular slit-lamp
examination at Union Hospital.
Mutation screening: Venous blood (5 ml) was collected from
the participants, and total human genomic DNA was isolated
with the DNA Isolation Kit for Mammalian Blood (Roche
Diagnostic Company, Indianapolis, IN). Considering that the
PAX6  mutation  is  a  genetic  factor  common  to  hereditary
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1141aniridia  and  at  least  20  different  mutations  of  PAX6  are
responsible  for  both  aniridia  and  congenital  cataract,  we
carried out mutation screening in the  PAX6 gene directly
without performing linkage analysis. Because the ten coding
exons (exon 5–14) have been thought to be the hot spots for
PAX6 mutation [8], eight pairs of primers (Table 1) were used
to  amplify  these  regions.  Briefly,  amplification  was
performed in the PTC-200 thermal cycler (MJ Research Inc.,
Waterdown, MA) in a 25-μl reaction mixture containing 1.5
mM  MgCl2,  0.2  mM  of  each  dNTP  (Qiagen,  Hilden,
Germany), 0.5 μM primers, 1 U of Taq DNA polymerase
(Qiagen), and 50 ng of genomic DNA. PCR was performed
as follows: an initial denaturation step was carried out for 3
min at 94 °C, nine cycles of 30 s at 94 °C, 30 s at the respective
annealing  temperature  (see  Table  1)  and  30  s  at  72  °C,
followed by the same 27 cycles with a separate annealing
temperature (Table 1). Direct bidirectional resequencing of all
PCR-amplified  products  was  performed  with  the  BigDye
Terminator Cycle Sequencing v3.1 kit (Applied Biosystems,
Foster City, CA) and electrophoresed on an ABI PRISM 3730
Genetic Analyzer (Applied Biosystems). Sequencing results
from the subjects and PAX6 consensus sequences from the
NCBI  human  genome  database  (NM_000280.3)  were
compared by using BLAST analysis. Mutation description
followed  the  nomenclature  recommended  by  the  Human
Genomic Variation Society.
Single-strand  conformation  polymorphism  analysis:  The
novel  variation  detected  in  exon  5  of  PAX6  was  further
evaluated in 28 available family members as well as normal
control  subjects  by  using  single-strand  conformation
polymorphism (SSCP) analysis, as described previously [9].
Briefly, 2 μl of undigested PCR products was mixed with 4
μl of the degenerating loading buffer, denatured at 95 °C for
10 min and immediately placed on ice; then loaded on 5%
polyacrylamide gels, and the DNA samples were separated by
electrophoresis overnight at 150 V. The DNA bands were
visualized by silver staining.
Sequencing of variants: We sequenced all variants detected
by  SSCP.  Following  electrophoresis,  the  DNA  bands  of
interest were excised, taking care to remove as much excess
gel as possible. The gel slices containing the PCR products
with 100 μl of dH2O were crushed and melted at 65 °C for 4–
5 h. PCR was performed as described above. PCR products
were sequenced using the BigDye Terminator v3.1 kit and the
ABI 3730 sequencer.
RESULTS
Clinical findings: We identified a large Chinese family with
49 living members in four generations (Figure 1). Bilateral
TABLE 1. PRIMERS USED FOR POLYMERASE CHAIN REACTION AMPLIFICATION AND SEQUENCING OF PAX6.
      Annealing
temperature °C
 
Exon Sense primer(5’-3’) Antisense primer (5’-3’) I II Product
size (bp)
5 GGCTGGTGGTCCTGTTGTCCTT CGAGCCCGAAGTCCCAGAAAG 61.5 55 483
6, 7 AAGCAAGGTCAGCACAAAAATAAATT GGAGGAGGTAAAGAGGAGAGAGCATT 60.5 54 648
8 TAAGGTTGTGGGTGAGCTGAGATG GGGAGAGTAGGGGACAGGCAAAGG 61.5 55 315
9 TTTGGTGAGGCTGTCGGGATATAAT TGCCCAGAGAAATAAAAAGACAGAAA 61.5 55 415
10 TTGGTTGGAGGTAATGGGAGTGG TGGCAGCAGAGCATTTAGCAGAC 61.5 55 334
11, 12 GGGGCTGGGCTCGACGTAG GCCACCACCAGCCGCACTTA 65 60 438
13 GGGGCTGTGGCTGTGTGATGT CCCCAGGGACAAGGAAAGCAA 61.5 55 333
14 CCAAACATGCAAACAAACAGAGGA TTCCAACTGATATCGTGCCTTCTG 61.5 55 570
Figure 1. Pedigree of a Chinese family with autosomal-dominant aniridia. Affected males and females are indicated by filled squares and
circles, respectively. Normal individuals are shown as empty symbols. Deceased individuals are indicated by slashes (/). The proband is
indicated by an arrow.
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1142total aniridia, congenital cataract, congenital nystagmus and
optic nerve hypoplasia were present in the proband (Figure 2).
Ophthalmic manifestations of affected members are listed in
Table 2, and all six patients had bilateral total aniridia and
congenital posterior subcapsular cataract. Corneal pannus was
present in three patients (Figure 2), and congenital nystagmus
was present in two patients.
Mutation analysis: Direct bidirectional sequencing of PAX6
in all affected patients revealed a heterozygous 17 bp deletion
(c.475_491delGGCCGTGCGACATTTCC)  within  the
paired domain in exon 5. The c.475_491del17 generates a
frameshift  and  a  premature  termination  12  codons
downstream  (p.Arg38ProfsX12).  SSCP  analysis  also
demonstrated that affected members in the family carried this
mutation, but the unaffected members of the family and 100
normal  Chinese  Han  controls  did  not  carry  the  mutation
(Figure  3).  In  all  affected  family  members,  the  same
heterozygous was confirmed by sequencing the extra bands
of PCR-SSCP products (Figure 4). These results suggest that
this novel mutation of PAX6 is not a rare polymorphism but a
causative  mutation  for  autosomal-dominant  congenital
aniridia and congenital cataract in this Chinese family.
DISCUSSION
In  the  present  study,  the  identified  novel  mutation  (c.
475_491del17)  generates  a  frameshift  and  a  premature
termination 12 codons downstream (p.Arg38ProfsX12). The
novel mutation in PAX6 predicted to result in a transcript that
is recognized by the nonsense-mediated mRNA decay system
[10],  leading  to  a  half  reduction  of  the  full-length PAX6
protein.  This  result  conforms  to  genotype–phenotype
correlation analysis, suggesting that mutations that introduce
Figure 2. Slit-lamp aspects of the ocular anterior segment of patients. The proband (III-25) exhibits aniridia without iris remnants (A); the
affected family member (II-13) presents corneal pannus (B); the normal subject (III-26) shows a complete iris (C).
TABLE 2. OCULAR PHENOTYPES IN SIX ANIRIDIA PATIENTS FROM A CHINESE FAMILY.
Patient Age (years)/sex Aniridia Cataracts Corneal pannus Nystagmus
II-13 54/F + + + -
III-5 41/F + + + +
III-7 40/M + +* + -
III-25** 31/F + + - +
IV-3 12/F + + - -
IV-4 12/F + + - -
The asterisk indicates after left cataract extraction and the double asterisk indicates the proband.
Figure 3. SSCP analysis of PAX6 mutation in exon 5. Each affected individual has one more band than normal family members. The arrow
indicates the extra band of the index patient (III-25).
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1143a premature termination codon (PTC) into the open reading
frame usually result in the aniridia phenotype [11].
The NTS of the paired domain is highly conserved and
plays an important role in contacting with the DNA. There is
a helix-turn-helix (HTH) unit, containing a β turn and three α
helices (helix 1, 2 and 3, residues 23-35, 40-45, and 50-63,
respectively) in the NTS; this helix-turn-helix unit makes
critical contacts in sugar phosphate backbone, major groove
and minor groove. Among those residues, Arg38, Pro39 and
Cys40 (Arg38 and Pro39 are in the turn between helices 1 and
2; Cys40 is a part of helix 2), contact with the sugar phosphate
backbone of the target DNA [12]. Interestingly, in our patients
the  deletion  mutation  (c.475_491del17,  p.Arg38ProfsX12)
affects  residues  (Arg38  to  Ser43)  involving  the  above-
mentioned  three  amino  acids  (Arg38,  Pro39,  and  Cys40).
Clinical data show that although there are different symptoms
in different patients, they have common and severe congenital
anomalies in eye development, including the near absence of
iris and posterior subcapsular cataract. We evaluated seven
unique  mutations  from  the  Human  PAX6  Allelic  Variant
Database [8] that refer to these three amino acids (Table 3)
[13-19]. Atchaneeyasakul et al. [16] reported that a novel
insertion/deletion mutation (c.474_480del12insGA) detected
in a Thai familial aniridia patient affects the three residues
completely.  The  patient  had  normal  best  corrected  visual
acuity  but  other  ocular  abnormalities,  including  partial
aniridia, juvenile glaucoma, posterior polar cataracts, corneal
pannus, foveal hypoplasia, and ptosis. With the exception of
one case [14], it appears that mutations impacting one or two
of the three amino acids are associated with an isolated defect
in iris development [13,17-19]. In that anomalistic case [14],
the patient with complex eye phenotypes was found to have
mutations  not  only  in  PAX6  but  also  in  neurofibromin  1
(NF1) and orthodenticle homeobox 2 (OTX2). In addition, a
neighboring mutation (p.41_43delAspIleSer) generates the
aniridia phenotype only [20]. We presume the region that the
residues (Arg38, Pro39, and Cys40) are in contact with play
an important role in the process of optical development, and
Figure 4. Sequence of the PCR product
of  exon  5  in  PAX6.  The  top
chromatogram represents the sequence
of a normal family member (normal).
The  middle  chromatogram  shows  a
reading  frame  shift  in  the  proband
(III-25,  heterozygous),  and  the  arrow
indicates the initiation of the mutation
site (beginning of overlapping peaks).
The bottom chromatogram exhibits the
sequence of the extra band of the SSCP
removed from the gel (mutant), and the
arrow  indicates  the  location  of  the
mutation.
TABLE 3. MUTATIONS IMPACTING ON RESIDUES (ARG38 TO SER43) CAUSE DIFFERENT PHENOTYPES.
Genotype    
cDNA Protein Phenotype Reference
c.471del9 p.37_39del Aniridia [12]
c.474C>T p.Arg38Trp Aniridia, microphthalmia, nystagmus, cataract [13]
c.474delC p.Arg38GlyfsX16 Aniridia [14]
c.474_485del12insGA p.Arg38GlufsX13 Aniridia, glaucoma, cataract, foveal hypoplasia, corneal pannus [15]
c.476_483del8 p.Pro39HisfsX14 Aniridia [16]
c.478insCC p.Cys40ArgfsX15 Iris hypoplasia [17]
c.482C>A p.Cys40X Aniridia [18]
c.483_491del9 p.41_43delAspIleSer Aniridia [19]
c.484A>G p.Asp41Gly Iris hypoplasia, nystagmus [20]
c.486delA p.Ile42PhefsX12 Aniridia, glaucoma [21]
c.487T>G p.Ile42Ser Aniridia, nystagmus, congenital cataract [22]
c.489T>C p.Ser43Pro Aniridia, cataract, nystagmus [23]
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1144an anomaly of this region may generate a complex phenotype
of ocular organs. Furthermore, mutations that affect residues
Asp41-Ser43 (Table 3) [20-24] lead to a consistent aniridia
phenotype;  two  of  these  mutations  result  in  aniridia
accompanied with cataract [23,24]. Although approximate
11% of the mutations in the database do not result in aniridia
or cataract, several mutations that refer to the 17 nucleotides
deleted  in  our  patients  generate  both  the  aniridia  and
congenital cataract phenotype.
This study identified a novel deletion mutation of PAX6
in a Chinese family with aniridia and congenital cataract. This
finding expands the mutation spectrum of PAX6 and is useful
and valuable for genetic counseling and prenatal diagnosis in
families with aniridia accompanied with congenital cataract.
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